Collonges sous Saleve, France

Jean-Yves Gillon


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Yves Gillon

Introduction: Jean-Yves Gillon is a distinguished inventor hailing from Collonges sous Salève, France. His work has notably advanced the field of biochemistry through his pioneering patent, which addresses critical issues related to metalloproteinase inhibition.

Latest Patents: Gillon holds a significant patent titled "Oxa-and thiadiazoles and their use as metalloproteinase inhibitors." This innovation features compounds represented by formulas (IA) or (IB), wherein W refers to various chemical groups such as HO(C=O)– or H(C=O)N(OH)–. The compounds are recognized for their capacity to act as inhibitors of matrix metalloproteinases, particularly MMP9 and MMP12.

Career Highlights: Throughout his career, Jean-Yves Gillon has made impactful contributions while working in research and development. He has been affiliated with Vernalis Limited and Laboratories Serono S.A., where he has played a vital role in advancing pharmaceutical research.

Collaborations: Gillon has collaborated with notable professionals in the field, including Andrew Paul Ayscough and Stephen John Davies. These collaborations have fostered an environment of innovation and discovery, enhancing the potential applications of his invention.

Conclusion: Jean-Yves Gillon's contributions to the realm of biochemistry through his patent on metalloproteinase inhibitors underscore the importance of innovation in medical research. His collaborative efforts and the practical applications of his inventions continue to influence the scientific community and offer hope for future advancements in therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…